Gael Forterre Volitionrx LTD (VNRX) insider trading activity

Gael Forterre is Chief Commercial Officer of VOLITIONRX LTD. Currently has a direct ownership of 153,782 shares of VNRX, which is worth approximately $50,748. The most recent transaction as insider was on Nov 01, 2025, when has been sold 1,753 shares (Common Stock) at a price of $0.43 per share, resulting in proceeds of $753. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 154K

4.44% 3M change

2.16% 12M change

Total Value Held $50,748

Gael Forterre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2025	SELL Payment of exercise price or tax liability	$753 $0.43 p/Share	1,753 Reduced 1.13%	153,782 Common Stock
Oct 04 2025	SELL Payment of exercise price or tax liability	$3,502 $0.65 p/Share	5,389 Reduced 3.35%	155,535 Common Stock
Sep 28 2025	SELL Payment of exercise price or tax liability	$3,301 $0.6 p/Share	5,503 Reduced 3.31%	160,924 Common Stock
Aug 15 2025	BUY Grant, award, or other acquisition	-	9,727 Added 5.52%	166,427 Common Stock
Aug 01 2025	SELL Payment of exercise price or tax liability	$1,770 $0.64 p/Share	2,766 Reduced 1.73%	156,700 Common Stock
Jun 01 2025	SELL Payment of exercise price or tax liability	$1,536 $0.77 p/Share	1,996 Reduced 1.24%	159,466 Common Stock
Jun 01 2025	SELL Payment of exercise price or tax liability	$2,117 $0.5 p/Share	4,234 Reduced 2.56%	161,462 Common Stock

Jun 01 2025	BUY Grant, award, or other acquisition	-	6,690 Added 3.88%	165,696 Common Stock
May 01 2025	SELL Payment of exercise price or tax liability	$1,812 $0.49 p/Share	3,698 Reduced 2.27%	159,006 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	5,523 Added 3.28%	162,704 Common Stock
Dec 01 2024	BUY Grant, award, or other acquisition	-	4,828 Added 2.98%	157,181 Common Stock
Oct 04 2024	SELL Payment of exercise price or tax liability	$4,781 $0.88 p/Share	5,433 Reduced 3.44%	152,353 Common Stock
Sep 28 2024	SELL Payment of exercise price or tax liability	$2,797 $0.58 p/Share	4,824 Reduced 2.97%	157,786 Common Stock
Sep 01 2024	BUY Grant, award, or other acquisition	-	10,240 Added 5.92%	162,610 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	15,250 Added 9.1%	152,370 Common Stock
Jun 01 2024	BUY Grant, award, or other acquisition	-	8,944 Added 6.12%	137,120 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	25,925 Added 16.82%	128,176 Common Stock
Oct 04 2023	SELL Payment of exercise price or tax liability	$3,758 $0.68 p/Share	5,527 Reduced 5.13%	102,251 Common Stock
Aug 03 2023	SELL Payment of exercise price or tax liability	$4,676 $1.3 p/Share	3,597 Reduced 3.23%	107,778 Common Stock
Jul 05 2023	BUY Grant, award, or other acquisition	-	20,700 Added 15.67%	111,375 Common Stock
Jan 12 2023	BUY Grant, award, or other acquisition	-	17,250 Added 15.98%	90,675 Common Stock
Oct 13 2022	BUY Grant, award, or other acquisition	-	8,050 Added 9.88%	73,425 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$7,088 $1.97 p/Share	3,598 Reduced 5.22%	65,375 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	-	13,308 Added 16.17%	68,973 Common Stock
Apr 07 2022	BUY Grant, award, or other acquisition	-	7,165 Added 11.4%	55,665 Common Stock

Gael Forterre

Chief Commercial Officer

Henderson, NV

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Value

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX

Account